Regulatory Landscape
Paper batch records slow release and invite errors. Here's how digital batch records fix traceability, speed, and GMP data integrity.
Simantini Singh Deo | Jun 26, 2026
Why Airflow Visualisation Has Become a Make-or-Break GMP Conversation
Vaibhavi M. | Jun 26, 2026
The Future Of Computerized Systems Validation (CSV)
Simantini Singh Deo | Jun 24, 2026
Other trending pieces on pharma manufacturing you may like to read
The Paperless Plant: How Digital Batch Records Are Transforming GMP Operations?
Paper batch records slow release and invite errors. Here's how digital batch records fix traceability, speed, and GMP data integrity.
by Simantini Singh Deo
Why Airflow Visualisation Has Become a Make-or-Break GMP Conversation
Airflow visualisation is now central to GMP — dynamic studies, contamination control, training and CCS, all reshaped by Annex 1 (2022).
by Vaibhavi M.
The Future Of Computerized Systems Validation (CSV)
CSV is being dismantled, not evolved. FDA's CSA shift, GAMP 5 Ed.2, and AI validation are rewriting pharma's rules in 2026.
by Simantini Singh Deo
AI-Driven Quality by Design (QbD): Advancing Predictive, Data-Driven Pharmaceutical Formulation Development Using Artificial Neural Networks
Hybrid QbD-AI integrates neural networks with traditional DoE, achieving R² values above 0.998 in real formulation development studies.
by Mr. Paritosh Singh
Can Regulators Trust AI-Generated Scientific Data?
FDA has 500+ AI submissions and rising. Hallucination rates hit 55% on niche topics. Here's the regulatory trust framework pharma must understand.
by Simantini Singh Deo
